However, the underlying targeted genes have not been identified.[50] Recently, Li further validated that IGF2BP3 forms a complex with RNA-binding protein ELAVL to enhance the stability of cell cycle-related genes, thereby promoting CRC proliferation.[51]. The gene discussed is IGF2BP3; the disease is colorectal carcinoma.